FDA Drug Recalls

Recalls / Class II

Class IID-0214-2024

Product

Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.

Brand name
Oxymetazoline Hydrochloride
Generic name
Oxymetazoline Hydrochloride
Active ingredient
Oxymetazoline Hydrochloride
Route
Nasal
NDC
63868-607
FDA application
M012
Affected lot / code info
Lot # SD23032, Exp 04/30/2026

Why it was recalled

CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

Recalling firm

Firm
Seaway Pharma Inc.
Manufacturer
CHAIN DRUG MARKETING ASSOCIATION INC.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
5 County Route 42, N/A, Massena, New York 13662-1569

Distribution

Quantity
7,992 bottles
Distribution pattern
MI, PA

Timeline

Recall initiated
2023-12-28
FDA classified
2024-01-04
Posted by FDA
2024-01-10
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0214-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Oxymetazoline Hydrochloride · FDA Drug Recalls